Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Rothstein

Showing results (161-170 of 215) with videos related to

Pageof 22
Sort By:
Glia|August 28, 2019
Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during agingMithilesh Kumar Jha, Youngjin Lee, Katelyn A Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementiaTao Zu, Yuanjing Liu, Monica Bañez-Coronel, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS miceAlexandra I Mot, Ying Li, Payam Dibaj, et al.
Nature Communications|August 14, 2025
Biobank-scale genetic characterization of Alzheimer's disease and related dementias across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survivalStanislav Tsitkov, Akshay Raju, Jie Wu, et al.
Nature|January 7, 2005
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expressionJeffrey D Rothstein, Sarjubhai Patel, Melissa R Regan, et al.
Muscle & Nerve|May 24, 2020
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunitiesJinsy A Andrews, James D Berry, Robert H Baloh, et al.
Molecular Neurodegeneration|February 16, 2019
Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathyJeannie Chew, Casey Cook, Tania F Gendron, et al.
Nature Genetics|January 24, 2006
Spectrin mutations cause spinocerebellar ataxia type 5Yoshio Ikeda, Katherine A Dick, Marcy R Weatherspoon, et al.
Pageof 22

Showing results (161-170 of 215) with videos related to

Sort By:
Pageof 22
Glia|August 28, 2019
Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during agingMithilesh Kumar Jha, Youngjin Lee, Katelyn A Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementiaTao Zu, Yuanjing Liu, Monica Bañez-Coronel, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS miceAlexandra I Mot, Ying Li, Payam Dibaj, et al.
Nature Communications|August 14, 2025
Biobank-scale genetic characterization of Alzheimer's disease and related dementias across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survivalStanislav Tsitkov, Akshay Raju, Jie Wu, et al.
Nature|January 7, 2005
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expressionJeffrey D Rothstein, Sarjubhai Patel, Melissa R Regan, et al.
Muscle & Nerve|May 24, 2020
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunitiesJinsy A Andrews, James D Berry, Robert H Baloh, et al.
Molecular Neurodegeneration|February 16, 2019
Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathyJeannie Chew, Casey Cook, Tania F Gendron, et al.
Nature Genetics|January 24, 2006
Spectrin mutations cause spinocerebellar ataxia type 5Yoshio Ikeda, Katherine A Dick, Marcy R Weatherspoon, et al.
Pageof 22